
<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<title>Validation of Functional Lumen Imaging Probe Panometry Esophageal Motility Classification Version 2.0: A Study of 805 Patients</title>
<style>

<style>
body {
    font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
    background: linear-gradient(135deg, #f0f4ff, #fafafa);
    color: #2c2c2c;
    padding: 40px;
}

/* Mindmap container */
.mindmap {
    max-width: 900px;
    margin: auto;
    font-size: 16px;
    line-height: 1.7;
}

.mindmap ul {
    margin: 0.5em 0 1em 1em;
    padding-left: 1.5em;
    list-style: disc;
    color: #555;
    font-size: 0.95em;
    font-weight: 400;
    line-height: 1.6;
}

.mindmap li::marker {
    color: #a855f7; /* prettier bullets */
}

.mindmap li {
    margin-bottom: 6px;
    padding-left: 4px;
}


/* Collapsible sections */
.mindmap details {
    border-left: 4px solid #8b5cf6;
    background: #ffffff;
    margin: 15px 0;
    padding: 16px 20px;
    border-radius: 16px;
    box-shadow: 0 4px 12px rgba(139, 92, 246, 0.12);
    transition: all 0.3s ease;
    position: relative;
}

/* Hover glow */
.mindmap details:hover {
    box-shadow: 0 6px 18px rgba(139, 92, 246, 0.2);
    background: linear-gradient(135deg, #ffffff, #f3f0ff);
}

/* Summary styling */
.mindmap summary {
    cursor: pointer;
    font-size: 1.15em;
    font-weight: 600;
    list-style: none;
    position: relative;
    padding-left: 28px;
    color: #4c1d95;
}

/* Custom arrow */
.mindmap summary::before {
    content: "▶";
    position: absolute;
    left: 0;
    top: 2px;
    transition: transform 0.3s ease;
    font-size: 1em;
    color: #7c3aed;
}

.mindmap details[open] > summary::before {
    transform: rotate(90deg);
}

/* Titles */
.mindmap summary strong {
    display: block;
    font-size: 1.3em;
    color: #4c1d95;
}

.mindmap summary em {
    font-style: normal;
    color: #6b21a8;
    font-size: 0.95em;
}

/* Description bullets */
.mindmap ul {
    padding-left: 22px;
    margin-top: 10px;
    margin-bottom: 12px;
}

.mindmap li {
    margin-bottom: 6px;
    font-size: 0.97em;
    color: #444;
    list-style-type: disc;
    position: relative;
    padding-left: 4px;
}

/* Nesting indent style */
.mindmap details > div > details {
    margin-left: 20px;
    border-color: #a855f7;
    background: #f9f5ff;
}

/* Fade-in effect */
.mindmap details[open] > div {
    animation: fadeIn 0.3s ease-in;
}

/* Description box */
.mindmap .desc-box {
    background: #fdfcff;
    border: 1px solid #e5d9fb;
    border-left: 4px solid #c084fc;
    padding: 4px 6px;
    margin: 12px 0 18px 0;
    border-radius: 12px;
    box-shadow: 0 1px 3px rgba(160, 104, 255, 0.06);
    transition: background 0.3s ease;
}

.mindmap .desc-box:hover {
    background: #f9f4ff;
}


button {
    background-color: #7c3aed;
    color: white;
    border: none;
    padding: 10px 16px;
    margin: 0 6px;
    font-size: 1em;
    border-radius: 8px;
    cursor: pointer;
    transition: background 0.3s ease;
}
button:hover {
    background-color: #6b21a8;
}


@keyframes fadeIn {
    from { opacity: 0; transform: translateY(-3px); }
    to { opacity: 1; transform: translateY(0); }
}


#level-controls button {
    background-color: rgba(124, 58, 237, 0.7); /* semi-transparent purple */
    color: white;
    border: none;
    padding: 8px 14px;
    margin: 0 6px;
    font-size: 1em;
    border-radius: 8px;
    cursor: pointer;
    transition: background 0.3s ease, transform 0.2s;
}

#level-controls button:hover {
    background-color: rgba(107, 33, 168, 0.85); /* slightly darker on hover */
    transform: scale(1.05);
}

#level-controls {
    position: fixed;
    bottom: 20px;
    left: 50%;
    transform: translateX(-50%);
    background: rgba(124, 58, 237, 0.1);
    padding: 8px 14px;
    border-radius: 12px;
    box-shadow: 0 4px 10px rgba(0, 0, 0, 0.1);
    z-index: 9999;
    backdrop-filter: blur(6px);
    cursor: move; /* shows move cursor */
}

</style>




</style>
</head>
<body>
<div id="level-controls" onmousedown="dragElement(this)">
    <button onclick="setMindmapLevel(1)">Level 1</button>
    <button onclick="setMindmapLevel(2)">Level 2</button>
    <button onclick="setMindmapLevel(3)">Level 3</button>
</div>

<div class="mindmap">

    <div class="mindmap">
        
        <details>
            <summary><strong>Validation of Functional Lumen Imaging Probe Panometry Esophageal Motility Classification Version 2.0: A Study of 805 Patients</strong></summary>
            <div>
                <ul><li>Journal: Neurogastroenterology &amp; Motility</li><li>Publication Date: 22 October 2025</li><li>Funding: R01 DK137775 (J.E.P. &amp; D.A.C.) from Public Health Service</li><li>Study Type: Multicenter validation study</li></ul>
                
        <details>
            <summary><strong>Knowledge Test</strong></summary>
            <div>
                <ul><li>1. What is the negative predictive value of normal FLIP panometry v2.0 for disorders of EGJ outflow?</li><li>2. What FLIP v2.0 classification is most strongly associated with Type I or II achalasia?</li><li>3. What pressure threshold at 60 mL fill volume differentiates &#x27;disordered&#x27; from &#x27;diminished&#x27; contractile response in FLIP v2.0?</li><li>4. What percentage of patients with non-spastic obstruction on FLIP v2.0 had a conclusive disorder of EGJ outflow on HRM/CCv4.0?</li><li>5. What percentage of Type III achalasia patients on HRM were classified as spastic obstruction on FLIP panometry v2.0?</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>FLIP Panometry Overview</strong></summary>
            <div>
                <ul><li>Assesses esophageal motility during sedated endoscopy;</li><li>Displays esophageal diameter topography + distensive pressure;</li><li>Evaluates EGJ opening mechanics + contractile response (CR) to luminal distension.</li></ul>
                
        <details>
            <summary><strong>Advantages over HRM</strong></summary>
            <div>
                <ul><li>Performed during sedated endoscopy → ↑ patient tolerance;</li><li>Real-time motility interpretation;</li><li>Procedure + interpretation ≈ several minutes.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>FLIP v1.0 to v2.0 Refinements</strong></summary>
            <div>
                <ul><li>Dallas Consensus introduced v2.0 → standardized protocol + refined classification;</li><li>EGJ opening criteria unchanged (nomenclature only);</li><li>CR patterns updated: impaired/disordered CR in v1.0 subdivided into diminished vs. disordered CR;</li><li>Obstruction w/ weak CR reclassified into non-spastic + spastic subtypes → improved achalasia phenotyping.</li></ul>
                
        <details>
            <summary><strong>Key Changes in CR Patterns (v1.0 → v2.0)</strong></summary>
            <div>
                <ul><li>Impaired/Disordered CR (v1.0) → Diminished CR OR Disordered CR (v2.0);</li><li>Differentiation based on 40 mmHg pressure threshold @ 60 mL fill volume.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Key Changes in Motility Classifications (v1.0 → v2.0)</strong></summary>
            <div>
                <ul><li>Obstruction w/ weak CR (v1.0) → Non-spastic obstruction OR Spastic obstruction (v2.0);</li><li>Weak (v1.0) → Hypocontractility OR Possible spasm (v2.0);</li><li>Spastic reactive (v1.0) → Spastic obstruction OR Possible obstruction OR Possible spasm (v2.0).</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Methodology</strong></summary>
            <div>
                <ul><li>Multicenter study @ 2 tertiary esophageal centers;</li><li>805 adult patients (18-91 yrs);</li><li>Consecutively enrolled in registries (Jan 2020 – May 2024);</li><li>Included: FLIP + HRM completed;</li><li>Excluded: technically limited studies, prior foregut surgery, esophageal mechanical obstruction (&gt;3cm hiatal hernia, stricture, EoE, severe reflux esophagitis).</li></ul>
                
        <details>
            <summary><strong>FLIP Study Protocol</strong></summary>
            <div>
                <ul><li>16-cm FLIP catheter (EndoFLIP EF-322N);</li><li>Performed during sedated EGD (moderate sedation/propofol);</li><li>Catheter positioned w/ distal 1-3 impedance sensors beyond EGJ;</li><li>Bag filled stepwise 10-mL increments (40 mL → 70 mL);</li><li>Each distension volume maintained 30-60s.</li></ul>
                
        <details>
            <summary><strong>FLIP Data Analysis</strong></summary>
            <div>
                <ul><li>Post-endoscopy using customized program (wklytics.com/nmgi);</li><li>Raters blinded to clinical details (HRM, TBE);</li><li>Interpretation used FLIP v1.0 + v2.0 criteria;</li><li>Assessed CR pattern (50-70 mL fill) + EGJ opening (EGJ-DI @ 60 mL, max EGJ diameter @ 60-70 mL).</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>HRM Protocol</strong></summary>
            <div>
                <ul><li>4.2-mm solid-state assembly;</li><li>Transnasal placement (hypopharynx to stomach);</li><li>CCv4.0 protocol: 10x 5-mL liquid swallows (supine), then 5x 5-mL liquid swallows (upright);</li><li>Investigators blinded to FLIP/TBE results.</li></ul>
                
        <details>
            <summary><strong>HRM Diagnostic Criteria (CCv4.0)</strong></summary>
            <div>
                <ul><li>Abnormal IRP: &gt;15 mmHg (supine) OR &gt;12 mmHg (upright).</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Role of Timed Barium Esophagram (TBE)</strong></summary>
            <div>
                <ul><li>Applied for inconclusive HRM (EGJOO, absent contractility w/ IRP @ upper limit of normal);</li><li>Upright position, 200 mL low-density barium;</li><li>Images @ 1, 2, 5 min;</li><li>12.5 mm barium tablet if no significant retention @ 5 min.</li></ul>
                
        <details>
            <summary><strong>TBE Abnormal Criteria</strong></summary>
            <div>
                <ul><li>Barium column height &gt;5 cm @ 5 min OR Barium column height &gt;5 cm @ 1 min + tablet impaction → defines conclusive disorders of EGJ outflow.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>TBE Normal Criteria</strong></summary>
            <div>
                <ul><li>Indicates normal EGJ outflow.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>TBE Inconclusive Criteria</strong></summary>
            <div>
                <ul><li>Barium column height &gt;5 cm @ 1 min &amp; ≤5 cm @ 5 min (no tablet/tablet passage) OR Barium height ≤5 cm @ 1 min w/ tablet impaction → interpreted as inconclusive EGJ outflow.</li><li>Note: Inconclusive HRM/CCv4.0 results excluded from primary analysis (n=101); assessed in secondary analysis.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>FLIP Panometry v2.0 Classification Criteria</strong></summary>
            <div>
                <ul><li>Standardized definitions for contractile response (CR) patterns + EGJ opening classifications;</li><li>Used to assign overall motility classification.</li></ul>
                
        <details>
            <summary><strong>Contractile Response (CR) Patterns</strong></summary>
            <div>
                <ul><li>Evaluated during 50-70 mL fill volume.</li></ul>
                
        <details>
            <summary><strong>Normal CR</strong></summary>
            <div>
                <ul><li>&gt;1 distinct antegrade contractions (≥6-cm axial length);</li><li>Associated w/ FLIP pressure rise &gt;10 mmHg;</li><li>W/ or w/o repetitive antegrade contraction;</li><li>Not meeting spastic CR criteria.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Diminished CR</strong></summary>
            <div>
                <ul><li>Contractility present, but not normal/spastic;</li><li>FLIP pressure (w/ 60 mL EGJ-DI) ≤40 mmHg.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Disordered CR</strong></summary>
            <div>
                <ul><li>Contractility present, but not normal/spastic;</li><li>FLIP pressure (w/ 60 mL EGJ-DI) &gt;40 mmHg.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Absent CR</strong></summary>
            <div>
                <ul><li>No contractile activity in esophageal body.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Spastic CR</strong></summary>
            <div>
                <ul><li>Presence of any: Sustained occluding contractions OR Sustained lower esophageal sphincter contractions.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>EGJ Opening Classifications</strong></summary>
            <div>
                <ul><li>Based on EGJ-DI @ 60 mL fill volume + maximum EGJ diameter @ 60-70 mL fill volume.</li></ul>
                
        <details>
            <summary><strong>Reduced EGJ Opening</strong></summary>
            <div>
                <ul><li>EGJ-DI &lt;2.0 mm²/mmHg AND Max EGJ diameter &lt;12 mm.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Inconclusive EGJ Opening</strong></summary>
            <div>
                <ul><li>EGJ-DI &lt;2.0 mm²/mmHg OR Max EGJ diameter &lt;16 mm;</li><li>Not meeting &#x27;reduced EGJ opening&#x27; criteria.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Normal EGJ Opening</strong></summary>
            <div>
                <ul><li>EGJ-DI ≥2.0 mm²/mmHg AND Max EGJ diameter ≥16 mm.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>FLIP Panometry v2.0 Motility Classifications</strong></summary>
            <div>
                <ul><li>Combinations of EGJ opening + CR patterns.</li></ul>
                
        <details>
            <summary><strong>Normal Motility</strong></summary>
            <div>
                <ul><li>Normal EGJ opening + Normal CR.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Hypocontractility</strong></summary>
            <div>
                <ul><li>Normal EGJ opening + Absent OR Diminished CR.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Possible Spasm</strong></summary>
            <div>
                <ul><li>Normal EGJ opening + Spastic OR Disordered CR.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Possible Obstruction</strong></summary>
            <div>
                <ul><li>Inconclusive EGJ opening + Anya CR pattern (CR pattern should be specified).</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Spastic Obstruction</strong></summary>
            <div>
                <ul><li>Reduced EGJ opening + Spastic OR Disordered CR.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Obstruction w/ Normal Contractility</strong></summary>
            <div>
                <ul><li>Reduced EGJ opening + Normal CR.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Non-spastic Obstruction</strong></summary>
            <div>
                <ul><li>Reduced EGJ opening + Absent OR Diminished CR.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Study Results</strong></summary>
            <div>
                <ul><li>Primary analysis: 704 patients w/ conclusive HRM/CCv4.0 diagnoses;</li><li>Secondary analysis: 101 patients w/ inconclusive HRM/CCv4.0 diagnoses.</li></ul>
                
        <details>
            <summary><strong>Cohort Characteristics (n=805)</strong></summary>
            <div>
                <ul><li>Mean age: 55 (SD 17) yrs;</li><li>62% female;</li><li>Dysphagia: 75% (most common indication);</li><li>66% underwent FLIP + HRM on same day;</li><li>Most frequent HRM: Normal (33%), Achalasia (30%).</li></ul>
                
        <details>
            <summary><strong>FLIP v2.0 Classification Distribution (Total Cohort)</strong></summary>
            <div>
                <ul><li>Normal motility: 19%;</li><li>Hypocontractility: 11%;</li><li>Non-spastic obstruction: 23%;</li><li>Spastic obstruction: 11%;</li><li>Possible spasm: 7.2%;</li><li>Possible obstruction: 28%;</li><li>Obstruction w/ normal contractility: 0 patients.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Clinical Associations by FLIP v2.0 Classification</strong></summary>
            <div>
                <ul><li>Dysphagia: common across all classifications;</li><li>Reflux: ↑ in normal, hypocontractility, possible spasm;</li><li>Mild esophagitis (LA A/B): ↑ in normal, hypocontractility;</li><li>Hiatal hernia (≤3cm): ↓ in non-spastic obstruction.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>FLIP Panometry Evaluation Findings (Primary Analysis, n=704)</strong></summary>
            <div>
                <ul><li>EGJ opening classifications:</li><li>Normal EGJ opening: 266 (38%) patients;</li><li>Inconclusive EGJ opening: 199 (28%) patients;</li><li>Reduced EGJ opening: 239 (34%) patients.</li></ul>
                
        <details>
            <summary><strong>EGJ Opening &amp; HRM Correlation</strong></summary>
            <div>
                <ul><li>Normal EGJ opening: 98.5% had normal EGJ outflow per HRM/CCv4.0;</li><li>Reduced EGJ opening: 81.6% had disorder of EGJ outflow.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>CR Patterns Distribution</strong></summary>
            <div>
                <ul><li>Normal CR: 158 (22.4%) patients;</li><li>Diminished CR: 85 (12.1%) patients;</li><li>Absent CR: 252 (35.8%) patients;</li><li>Disordered CR: 113 (16.1%) patients;</li><li>Spastic CR: 96 (13.6%) patients.</li></ul>
                
        <details>
            <summary><strong>CR &amp; Achalasia/EGJOO</strong></summary>
            <div>
                <ul><li>Only 1 patient w/ normal CR had achalasia (Type III);</li><li>Only 3 patients w/ normal CR had conclusive EGJOO.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>FLIP v2.0 Motility Classifications &amp; HRM/CCv4.0 Alignment</strong></summary>
            <div>
                <ul><li>FLIP v2.0 classifications frequently paralleled HRM/CCv4.0 diagnoses.</li></ul>
                
        <details>
            <summary><strong>Normal Motility (FLIP v2.0)</strong></summary>
            <div>
                <ul><li>137 patients classified as normal;</li><li>81% had normal motility (HRM/CCv4.0);</li><li>12% had IEM (HRM/CCv4.0);</li><li>99% negative predictive value for disorders of EGJ outflow;</li><li>0 patients w/ achalasia on HRM.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Hypocontractility (FLIP v2.0)</strong></summary>
            <div>
                <ul><li>78 patients classified as hypocontractility;</li><li>72% had absent contractility or IEM (HRM/CCv4.0);</li><li>27% had normal motility (HRM/CCv4.0);</li><li>1 patient had Type II achalasia (treatment deferred due to minimal symptoms, normal TBE).</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Non-spastic Obstruction (FLIP v2.0)</strong></summary>
            <div>
                <ul><li>163 patients classified as non-spastic obstruction;</li><li>77% had Type I (31%) or Type II (47%) achalasia;</li><li>8.0% had Type III achalasia;</li><li>5.5% had conclusive EGJOO;</li><li>Total 91% had a disorder of EGJ outflow by HRM/CCv4.0.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Spastic Obstruction (FLIP v2.0)</strong></summary>
            <div>
                <ul><li>76 patients classified as spastic obstruction;</li><li>32% had Type I (2.6%) or Type II (29%) achalasia;</li><li>21% had Type III achalasia.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Type III Achalasia (HRM) &amp; FLIP v2.0</strong></summary>
            <div>
                <ul><li>Among 37 patients w/ Type III achalasia (HRM):</li><li>43% classified as spastic obstruction (FLIP v2.0);</li><li>35% classified as non-spastic obstruction (FLIP v2.0);</li><li>22% classified as possible obstruction (FLIP v2.0).</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Possible Obstruction (FLIP v2.0)</strong></summary>
            <div>
                <ul><li>199 patients classified as possible obstruction;</li><li>38% had normal motility (HRM/CCv4.0);</li><li>26% had Type I/II achalasia (HRM/CCv4.0);</li><li>16% had IEM (HRM/CCv4.0).</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Comparison: FLIP v1.0 vs. FLIP v2.0</strong></summary>
            <div>
                <ul><li>Refinements in v2.0 aimed to improve alignment w/ HRM findings.</li></ul>
                
        <details>
            <summary><strong>Obstruction w/ Weak CR (FLIP v1.0) → v2.0 Reclassification</strong></summary>
            <div>
                <ul><li>v1.0: 26% Type I achalasia, 43% Type II achalasia, 10% Type III achalasia;</li><li>v2.0 Non-spastic obstruction: 31% Type I, 47% Type II, 8.0% Type III achalasia;</li><li>v2.0 Spastic obstruction: 3% Type I, 29% Type II, 21% Type III achalasia.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Weak (FLIP v1.0) → v2.0 Reclassification</strong></summary>
            <div>
                <ul><li>v1.0: 32% absent contractility, 27% IEM, 2.7% hypercontractile esophagus;</li><li>v2.0 Hypocontractility: 44% absent contractility, 28% IEM, 0% hypercontractile/spasm;</li><li>v2.0 Possible spasm: 2.0% absent contractility, 24% IEM, 7.8% hypercontractile esophagus, 0% spasm.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Spastic Reactive (FLIP v1.0) → v2.0 Reclassification</strong></summary>
            <div>
                <ul><li>v1.0: 13% Type III achalasia;</li><li>v2.0 Spastic obstruction: 21% of Type III achalasia;</li><li>v2.0 Possible obstruction: 4.0% of Type III achalasia;</li><li>v2.0 Possible spasm: 0% Type III achalasia.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
            </div>
        </details>
        
        <details>
            <summary><strong>Discussion &amp; Clinical Implications</strong></summary>
            <div>
                <ul><li>FLIP panometry v2.0 effectively categorizes esophageal motility;</li><li>Frequently aligns w/ HRM/CCv4.0 diagnoses;</li><li>Well-tolerated approach, complements/alternative to HRM.</li></ul>
                
        <details>
            <summary><strong>Normal Motility (FLIP v2.0) Significance</strong></summary>
            <div>
                <ul><li>High negative predictive value (99%) for disorders of EGJ outflow;</li><li>0 patients w/ achalasia;</li><li>Can rule out achalasia → guide management towards reflux/functional syndrome w/o HRM;</li><li>Proportion of DES (1-14%) + IEM (7-17%) observed aligns w/ healthy volunteers.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Non-spastic Obstruction (FLIP v2.0) Significance</strong></summary>
            <div>
                <ul><li>Strongly associated w/ achalasia or conclusive EGJOO;</li><li>Positive predictive value: 91%;</li><li>77% were non-spastic (Type I/II) achalasia (vs. 69% w/ v1.0 obstruction w/ weak CR).</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Refinement of Impaired/Disordered CR (IDCR) in v2.0</strong></summary>
            <div>
                <ul><li>Differentiation into diminished CR vs. disordered CR (based on 40 mmHg pressure @ 60 mL EGJ-DI);</li><li>Improved subtyping of achalasia (non-spastic vs. spastic);</li><li>Spastic obstruction (v2.0) encompassed nearly half of Type III achalasia (16 patients, 21% of spastic obstruction cases);</li><li>Also included 29% Type II achalasia → suggests spastic variant of Type II achalasia identifiable by FLIP.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Hypocontractility (FLIP v2.0) Significance</strong></summary>
            <div>
                <ul><li>Enhanced identification of hypocontractile disorders;</li><li>72% had IEM or absent contractility (vs. 59% w/ v1.0 weak motility).</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Possible Spasm (FLIP v2.0) Limitations</strong></summary>
            <div>
                <ul><li>Intended to distinguish primary esophageal spasm from hypocontractile disorders;</li><li>Only 8% had hypercontractile esophagus or DES per HRM/CCv4.0;</li><li>65% had normal HRM → suggests impaired secondary peristalsis, not spastic variant w/ normal HRM;</li><li>Area requires further refinement + validation.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Study Strengths</strong></summary>
            <div>
                <ul><li>Large patient cohort (n=805) w/ comprehensive esophageal evaluations;</li><li>Application of HRM + CCv4.0;</li><li>Cohort distinct from initial FLIP v1.0 study;</li><li>Multicenter design → ↑ generalizability;</li><li>Higher prevalence of achalasia → strength, as achalasia identification is critical.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Study Limitations</strong></summary>
            <div>
                <ul><li>Absence of definitive gold standard for diagnosis (key challenge in motility research);</li><li>Inconclusive/discordant diagnoses still occur w/ HRM + CCv4.0 + TBE;</li><li>FLIP goal not to replicate HRM (assess distinct physiological processes: FLIP secondary peristalsis, HRM primary peristalsis);</li><li>Two esophageal referral centers → may not reflect community practice patient characteristics.</li></ul>
                
            </div>
        </details>
        
        <details>
            <summary><strong>Future Directions</strong></summary>
            <div>
                <ul><li>Explore FLIP v2.0 application in broader populations;</li><li>Assess longitudinal outcomes;</li><li>Further define unique subgroups of interest;</li><li>Diagnostic paradigm will continue to develop w/ clinical experience + research.</li></ul>
                
            </div>
        </details>
        
            </div>
        </details>
        
            </div>
        </details>
        
    </div>
    
</div>


<script>
function setMindmapLevel(level) {
    const allDetails = document.querySelectorAll('.mindmap details');

    // Close all
    allDetails.forEach(detail => detail.removeAttribute('open'));

    // Open based on depth
    allDetails.forEach(detail => {
        let depth = 0;
        let parent = detail.parentElement;
        while (parent && parent.tagName !== 'BODY') {
            if (parent.tagName === 'DETAILS') depth++;
            parent = parent.parentElement;
        }
        if (depth < level) detail.setAttribute('open', '');
    });
}

// Automatically open to level 1 on page load
window.addEventListener('DOMContentLoaded', () => {
    setMindmapLevel(1);
});

function dragElement(elmnt) {
    let pos1 = 0, pos2 = 0, pos3 = 0, pos4 = 0;

    const onMouseDown = (e) => {
        e.preventDefault();
        pos3 = e.clientX;
        pos4 = e.clientY;
        document.onmouseup = closeDragElement;
        document.onmousemove = elementDrag;
    };

    const elementDrag = (e) => {
        e.preventDefault();
        pos1 = pos3 - e.clientX;
        pos2 = pos4 - e.clientY;
        pos3 = e.clientX;
        pos4 = e.clientY;
        elmnt.style.top = (elmnt.offsetTop - pos2) + "px";
        elmnt.style.left = (elmnt.offsetLeft - pos1) + "px";
        elmnt.style.transform = "none"; // cancel centering transform
        elmnt.style.bottom = "auto"; // cancel fixed bottom
    };

    const closeDragElement = () => {
        document.onmouseup = null;
        document.onmousemove = null;
    };

    onMouseDown(event);
}
</script>


</body>
</html>
